VELOSBIO
VelosBio is an operator of a clinical-stage biopharmaceutical company intended to develop novel, first-in-class, ROR1-directed therapeutics to transform the lives of patients with cancer. The company's ROR1-directed therapeutics is a cell-surface protein that is expressed on many hematologic and solid tumors but is absent from normal tissues, making it an attractive tumor-specific therapeutic target and has demonstrated positive preclinical results in tumor models, enabling institutions to get novel targeted therapies for use as monotherapy or in combination across a broad range of cancers. It was founded in 2017 and headquartered in San Diego, California.
VELOSBIO
Social Links:
Industry:
Biotechnology Health Care Medical
Founded:
2017-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.velosbio.com
Total Employee:
1+
Status:
Active
Contact:
+44 (0)20 7290 1050
Email Addresses:
[email protected]
Total Funding:
202.7 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail IPv6 Microsoft Azure DNS Microsoft AWS Global Accelerator Cisco Ironport Cloud ATT DNS
Similar Organizations
Decoy Biosystems
Decoy Biosystems is a biotechnology company developing novel, multi-targeted products designed to eliminate viral and bacterial infections.
Editas Medicine
Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics.
Electra Therapeutics
Electra Therapeutics is a clinical stage biotechnology company developing therapies for cancer and other immunological diseases.
Elucida Oncology
Elucida Oncology is developing targeted C'Dot Drug Conjugates (CDCs) for patients with primary solid tumor and metastatic cancer.
Flash Therapeutics
Flash Therapeutics is a new gene therapy company developing gene and cell-based therapies by leveraging its proprietary lentiviral platform.
Histogenics
Histogenics is a tissue regeneration company developing breakthrough treatments for long-lasting joint repair.
Intocell
Intocell is a biotechnology company that develops antibody drug conjugate (ADC) platform technologies.
Lineage Cell Therapeutics
Lineage Cell Therapeutics is a clinical-stage biotechnology company developing novel cellular therapies to treat unmet medical needs.
Knopp Biosciences
Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Oncolinx
Oncolinx is developing antibody-drug conjugates.
Optieum Biotechnologies
OB is a biotechnology company committed to developing innovative scFv antibody-based therapies for the treatment of patients with cancers.
ORIG3N
ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Viking Global Investors
Viking Global Investors investment in Series B - VelosBio
Pappas Capital
Pappas Capital investment in Series B - VelosBio
Farallon Capital Management
Farallon Capital Management investment in Series B - VelosBio
Janus Henderson Investors
Janus Henderson Investors investment in Series B - VelosBio
Foresite Capital
Foresite Capital investment in Series B - VelosBio
Arix Bioscience
Arix Bioscience investment in Series B - VelosBio
Sofinnova Investments
Sofinnova Investments investment in Series B - VelosBio
T. Rowe Price
T. Rowe Price investment in Series B - VelosBio
Cormorant Asset Management
Cormorant Asset Management investment in Series B - VelosBio
Venrock
Venrock investment in Series B - VelosBio
Official Site Inspections
http://www.velosbio.com
- Host name: a08dcc0307b4874ea.awsglobalaccelerator.com
- IP address: 76.223.68.176
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
